SE7906272L - Sett att framstella en immunglobulinlosning - Google Patents

Sett att framstella en immunglobulinlosning

Info

Publication number
SE7906272L
SE7906272L SE7906272A SE7906272A SE7906272L SE 7906272 L SE7906272 L SE 7906272L SE 7906272 A SE7906272 A SE 7906272A SE 7906272 A SE7906272 A SE 7906272A SE 7906272 L SE7906272 L SE 7906272L
Authority
SE
Sweden
Prior art keywords
degrees
solns
soln
sio2
damp
Prior art date
Application number
SE7906272A
Other languages
English (en)
Swedish (sv)
Inventor
K Bunnig
Original Assignee
Blutspendedienst Des Landesver
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Des Landesver filed Critical Blutspendedienst Des Landesver
Publication of SE7906272L publication Critical patent/SE7906272L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7906272A 1978-08-25 1979-07-23 Sett att framstella en immunglobulinlosning SE7906272L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782837168 DE2837168A1 (de) 1978-08-25 1978-08-25 Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung

Publications (1)

Publication Number Publication Date
SE7906272L true SE7906272L (sv) 1980-02-26

Family

ID=6047909

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7906272A SE7906272L (sv) 1978-08-25 1979-07-23 Sett att framstella en immunglobulinlosning

Country Status (7)

Country Link
US (1) US4322403A (de)
JP (1) JPS5547627A (de)
AT (1) AT368886B (de)
DE (1) DE2837168A1 (de)
FR (1) FR2433946A1 (de)
GB (1) GB2032437B (de)
SE (1) SE7906272L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
DE3310150A1 (de) * 1983-03-21 1984-09-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
EP0973384A4 (de) * 1997-02-13 2004-10-13 Sky High Llc Organkonservierungslösung
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
ES2776657T3 (es) 2005-06-14 2020-07-31 Amgen Inc Formulaciones de proteínas autotamponantes
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US20100278935A1 (en) * 2007-07-30 2010-11-04 Stacey William C Immune System Modulator Formulation
EP3528787B1 (de) 2016-10-21 2026-01-07 Amgen Inc. Pharmazeutische formulierungen und verfahren zur herstellung davon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6702923A (de) * 1966-04-06 1967-10-09
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
DE1792555C3 (de) * 1968-09-19 1980-01-10 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung einer für die intravenöse Anwendung geeigneten Gammaglobulinlösung
IL34079A (en) * 1969-04-01 1973-02-28 Upjohn Co Purification of ypsilon-globulins
US3607857A (en) * 1970-03-03 1971-09-21 Upjohn Co Process of removing acrinol from gamma globulin using siliceous material such as silica gel
FR2267115B1 (de) * 1974-04-12 1977-11-10 Merieux Inst
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin

Also Published As

Publication number Publication date
FR2433946A1 (fr) 1980-03-21
ATA505279A (de) 1982-04-15
AT368886B (de) 1982-11-25
DE2837168A1 (de) 1980-03-06
GB2032437B (en) 1982-10-27
JPS5547627A (en) 1980-04-04
US4322403A (en) 1982-03-30
GB2032437A (en) 1980-05-08

Similar Documents

Publication Publication Date Title
SE7906272L (sv) Sett att framstella en immunglobulinlosning
ATE237351T1 (de) Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
LU91610I2 (fr) Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
DE69116305D1 (de) Verfahren zur Herstellung von Trehalulose und Isomaltulose
FI972622A0 (fi) Pitkävaikutteisia rakeisia valmisteita ja niiden valmistusmenetelmä
MX9101274A (es) Analogos de anillos fusionados de heterociclos no aromaticos nitrogenados
ATE16567T1 (de) Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung.
ATE79623T1 (de) Pyrazolo(3,4-d>pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel.
ATE158184T1 (de) Herstellung und verwendung von transfer-faktor
NO933200L (no) Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
FI844596L (fi) Foerfarande foer framstaellning av oligosackarid-innehaollande produkter ur biomassa, produkter innehaollande oligosackarid samt deras anvaendning.
FI931332A0 (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
FR2342733A1 (fr) Derives de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2643371B1 (fr) Nouveaux derives de l'acide 2-amino pentanedioique, leur procede de preparation et leur application comme medicaments
SE8005399L (sv) Framstellning av sampolymerer av propen och but-1-en
TW242110B (de)
FI103055B1 (fi) Menetelmä tiomarinolijohdannaisten valmistamiseksi
EP0441395A3 (en) Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infections
FR2340093A1 (fr) Derives de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
BG96578A (bg) Метод за получаване на пречистени лизозимни димери
FR2430952A1 (fr) Nouveaux derives acetyleniques de l'androst 4-ene, leur procede de preparation et leur application comme medicament
ATE15803T1 (de) Cephalosporinderivate, ihre herstellung und anwendung.
GB2007244A (en) Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP
CA2062105A1 (en) Purified mite allergen
SU1273977A1 (ru) Способ моделировани сепсиса

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7906272-5